Shannon Turley
Company: Genentech Inc
Job title: Vice President - Immunology & OMNI Biomarker Discovery
Seminars:
Revealing the Latest Updates in the TGF-β for Immuno-Oncology Pipeline 8:30 am
Discussing the cell types that the compound has a mechanism of action on What can a TGF-β inhibitor do relative to other targeted therapies or checkpoint inhibitors? Looking to the future for TGF-β drug developmentRead more
day: Day One
Discussion Panel: Forecasting the Future Developments in Targeting TGF-β for Immuno-Oncology: Where May the Next 3-5 Years Take Us? 11:30 am
day: Day One